Artículos por temáticas

High prevalence of restless legs syndrome among patients with polycytemia vera treated with venesectio.

Tobiasson M, Alyass B, Söderlund S, Birgegård G.

Med Oncol. 2010 Mar;27(1):105-7. doi: 10.1007/s12032-009-9180-5.

Evaluation of spasticity in children with cerebral palsy using Ashworth and Tardieu Scales compared with laboratory measures.

Alhusaini AA, Dean CM, Crosbie J, Shepherd RB, Lewis J.

J Child Neurol. 2010 Oct;25(10):1242-7. doi: 10.1177/0883073810362266.

Increased auditory startle reflex in children with functional abdominal pain.

Bakker MJ, Boer F, Benninga MA, Koelman JH, Tijssen MA.

J Pediatr. 2010 Feb;156(2):285-91.e1. doi: 10.1016/j.jpeds.2009.08.045.

Effects of the novel endocannabinoid uptake inhibitor, LY2183240, on fear-potentiated startle and alcohol-seeking behaviors in mice selectively bred for high alcohol preference.

Powers MS, Barrenha GD, Mlinac NS, Barker EL, Chester JA.

Psychopharmacology (Berl). 2010 Dec;212(4):571-83. doi: 10.1007/s00213-010-1997-2.

[Confusion, gait ataxia and ophthalmoplegia in a patient with chronic alcohol consumption].

Niemann T, Erb S, Ott HW.

Praxis (Bern 1994). 2010 Mar 3;99(5):311-3. doi: 10.1024/1661-8157/a000540. German.

Metabolic acetate therapy improves phenotype in the tremor rat model of Canavan disease.

Arun P, Madhavarao CN, Moffett JR, Hamilton K, Grunberg NE, Ariyannur PS, Gahl WA, Anikster Y, Mog S, Hallows WC, Denu JM, Namboodiri AM.

J Inherit Metab Dis. 2010 Jun;33(3):195-210. doi: 10.1007/s10545-010-9100-z.

Prevalence of incompletely penetrant Huntington's disease alleles among individuals with major depressive disorder.

Perlis RH, Smoller JW, Mysore J, Sun M, Gillis T, Purcell S, Rietschel M, Nöthen MM, Witt S, Maier W, Iosifescu DV, Sullivan P, Rush AJ, Fava M, Breiter H, Macdonald M, Gusella J.

Am J Psychiatry. 2010 May;167(5):574-9. doi: 10.1176/appi.ajp.2009.09070973.

A 13-year-old boy with ataxia 4 weeks after a near-drowning accident.

León M, Alave J, Chaparro E, Bustamante B, Seas C.

Clin Infect Dis. 2010 Aug 1;51(3):326-7, 363-4. doi: 10.1086/653941. No abstract available.

Cognitive and functional decline in Huntington's disease: dementia criteria revisited.

Peavy GM, Jacobson MW, Goldstein JL, Hamilton JM, Kane A, Gamst AC, Lessig SL, Lee JC, Corey-Bloom J.

Mov Disord. 2010 Jul 15;25(9):1163-9. doi: 10.1002/mds.22953.

Lingual protrusion dystonia: frequency, etiology and botulinum toxin therapy.

Esper CD, Freeman A, Factor SA.

Parkinsonism Relat Disord. 2010 Aug;16(7):438-41. doi: 10.1016/j.parkreldis.2010.04.007.

Nerve excitability studies characterize Kv1.1 fast potassium channel dysfunction in patients with episodic ataxia type 1.

Tomlinson SE, Tan SV, Kullmann DM, Griggs RC, Burke D, Hanna MG, Bostock H.

Brain. 2010 Dec;133(Pt 12):3530-40. doi: 10.1093/brain/awq318.

QEEG Measures in Huntington's Disease: A Pilot Study.

Hunter A, Bordelon Y, Cook I, Leuchter A.

PLoS Curr. 2010 Oct 25;2:RRN1192. doi: 10.1371/currents.RRN1192.

Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6.

Xiao J.

Hum Genet. 2010 Apr;127(4):469. No abstract available.

Zonisamide in Parkinson's disease: profile report.

Yang LP, Perry CM.

Drugs Aging. 2010 Jan 1;27(1):73-5. doi: 10.2165/11203950-000000000-00000. No abstract available.

Restorative approaches in Parkinson's Disease: which cell type wins the race?

Meyer AK, Maisel M, Hermann A, Stirl K, Storch A.

J Neurol Sci. 2010 Feb 15;289(1-2):93-103. doi: 10.1016/j.jns.2009.08.024. Review.